The fetal valproate syndrome - PubMed (original) (raw)
The fetal valproate syndrome
J H DiLiberti et al. Am J Med Genet. 1984 Nov.
Abstract
We evaluated seven children who had been exposed to sodium valproate (or valproic acid) in utero. A consistent facial phenotype was observed in all seven in addition to other birth defects in four. The facial changes consisted of epicanthal folds which continued inferiorly and laterally to form a crease or groove just under the orbit, flat nasal bridge, small upturned nose, long upper lip with a relatively shallow philtrum, a thin upper vermillion border, and downturned angles of the mouth. Hypospadias, strabismus, and psychomotor delay were found in two males; two children had nystagmus and two had low birth weight.
Similar articles
- Verification of the fetal valproate syndrome phenotype.
Ardinger HH, Atkin JF, Blackston RD, Elsas LJ, Clarren SK, Livingstone S, Flannery DB, Pellock JM, Harrod MJ, Lammer EJ, et al. Ardinger HH, et al. Am J Med Genet. 1988 Jan;29(1):171-85. doi: 10.1002/ajmg.1320290123. Am J Med Genet. 1988. PMID: 3125743 Review. - Fetal valproate syndrome: is there a recognisable phenotype?
Winter RM, Donnai D, Burn J, Tucker SM. Winter RM, et al. J Med Genet. 1987 Nov;24(11):692-5. doi: 10.1136/jmg.24.11.692. J Med Genet. 1987. PMID: 3123693 Free PMC article. - [Facial dysmorphism related to valproic acid ingestion during pregnancy].
Chevallier B, Hertz L, Lagardere B, Gallet JP. Chevallier B, et al. Arch Fr Pediatr. 1986 Aug-Sep;43(7):489-90. Arch Fr Pediatr. 1986. PMID: 3099722 French. - Fetal Valproate Syndrome - Still a Problem Today!
Wiedemann K, Stüber T, Rehn M, Frieauff E. Wiedemann K, et al. Z Geburtshilfe Neonatol. 2017 Oct;221(5):243-246. doi: 10.1055/s-0043-107619. Epub 2017 Oct 26. Z Geburtshilfe Neonatol. 2017. PMID: 29073690 English.
Cited by
- Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges.
Epstein RA, Moore KM, Bobo WV. Epstein RA, et al. Drug Healthc Patient Saf. 2014 Dec 24;7:7-29. doi: 10.2147/DHPS.S50556. eCollection 2015. Drug Healthc Patient Saf. 2014. PMID: 25565896 Free PMC article. Review. - Single-dose tolerance and pharmacokinetics of 2-n-propyl-2(E)-pentenoate (delta 2(E)-valproate) in healthy male volunteers.
Düsing RH. Düsing RH. Pharm Weekbl Sci. 1992 Jun 19;14(3A):152-8. doi: 10.1007/BF01962708. Pharm Weekbl Sci. 1992. PMID: 1502017 - Fetal valproate phenotype is recognisable by mid pregnancy.
Serville F, Carles D, Guibaud S, Dallay D. Serville F, et al. J Med Genet. 1989 May;26(5):348-9. doi: 10.1136/jmg.26.5.348. J Med Genet. 1989. PMID: 2499680 Free PMC article. No abstract available. - Metabolic disorders of embryogenesis.
Brown GK. Brown GK. J Inherit Metab Dis. 1994;17(4):448-58. doi: 10.1007/BF00711360. J Inherit Metab Dis. 1994. PMID: 7967495 Review. - Transcriptome Analysis in Hippocampus of Rats Prenatally Exposed to Valproic Acid and Effects of Intranasal Treatment of Oxytocin.
Matsuo K, Shinoda Y, Abolhassani N, Nakabeppu Y, Fukunaga K. Matsuo K, et al. Front Psychiatry. 2022 Mar 30;13:859198. doi: 10.3389/fpsyt.2022.859198. eCollection 2022. Front Psychiatry. 2022. PMID: 35432011 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical